Regenerative Medical Technology Group Inc.: accounts_payable
| Value | {"amount": 250755, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | superseded |
| Entity | Regenerative Medical Technology Group Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:54:01.844096+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cbdc86f4-2a85-497c-a963-9cdb09a56770
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-22-070224Retrieved: 2026-08-19T17:54:01.844096+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001760026/accounts-payable/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cbdc86f4-2a85-497c-a963-9cdb09a56770
History
- supersedes {"amount": 250756, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} (evidence 0001213900-22-024049)